Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
More in Startups
Figma announces new features to define how agents work on its platform
October 15, 2026
Ricursive Intelligence is betting on AI-designed chips to help solve the compute crisis
October 15, 2026
Flock CEO defends surveillance technology amid national backlash: ‘We shouldn’t pause progress’
October 15, 2026
Meet the five companies competing in the Startup Battlefield finals at Disrupt 2026
October 15, 2026
Gudea leverages AI to help organizations prevent social media crises before they erupt
October 15, 2026
CedarDB wants one database to handle both transactions and analytics, as AI agents raise the stakes
October 14, 2026
Latest News
விமர்சனத்திற்கு உள்ளாகும் எம்ஜி ஹெக்டர் டோமாஹாக் கார் சஸ்பென்ஷன்! என்ன பிரச்சினை?
October 15, 2026
4.6 மீட்டர் நீளம், பவர்ஃபுல் டர்போ எஞ்சின்… 2027ல் இந்தியா வருகிறது ரெனோ பிக்ஸ்டர் 7 சீட்டர் எஸ்யூவி!
October 15, 2026
BSA Gold Star 650 gets two new colours
October 15, 2026
What to expect from the new Audi Q3 ahead of launch tomorrow
October 15, 2026
Updated Bajaj Pulsar NS160 spotted testing
October 15, 2026
Mahindra XUV 3XO CNG vs rivals: price, specifications compared
October 15, 2026